GlassScriptPhysician profile
Arthur B Reitman
NPI 1184692691
$105,655.90
in general payments reported to CMS, 2019-2025
42 companies · $9,011 in 2025
The $9,011 reported for 2025 was more than what 88% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $38K · 2020: $17K · 2021: $14K · 2022: $11K · 2023: $13K · 2024: $3,664 · 2025: $9,011.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Consulting Fee: $10K · Travel and Lodging: $2,383 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,236.28 |
| Consulting Fee | $10,375.00 |
| Travel and Lodging | $2,382.97 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $69,514.82 | 2019-2025 | General - Balloons, Avvigo Guidance System, General - Vascular Access |
| Medtronic Vascular, INC. | $11,828.76 | 2019-2020 | |
| Medtronic, INC. | $5,700.76 | 2021-2024 | Corevalve Evolut R, Onyx Frontier, Symplicity G3 |
| Abiomed | $4,312.59 | 2019-2024 | Impella |
| Abbott Laboratories | $2,922.96 | 2019-2025 | Mitraclip, Pressurewire, Xience Skypoint |
| Shockwave Medical, INC | $2,644.91 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Edwards Lifesciences Corporation | $1,548.36 | 2019-2025 | Sapien 3 Ultra Resilia, Pascal, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Philips North America LLC | $1,171.57 | 2019-2024 | (Bq9) Coronary Ivus |
| Siemens Medical Solutions USA, INC. | $674.03 | 2020-2024 | Naeotom Alpha, Magnetom Sola, Somatom Force |
| Teleflex LLC | $604.02 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $598.58 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $445.65 | 2019-2025 | |
| Heartflow, INC. | $440.79 | 2023-2025 | Ffrct |
| Janssen Pharmaceuticals, INC | $326.16 | 2019-2024 | Xarelto |
| Biotronik INC. | $303.11 | 2022-2024 | Orsiro Mission |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corindus INC. | $287.54 | 2019 | |
| Pfizer INC. | $270.02 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $214.37 | 2019-2025 | Camzyos |
| Livanova USA, INC. | $145.58 | 2020 | |
| Ge Healthcare | $142.80 | 2023 | |
| Merck Sharp & Dohme LLC | $141.11 | 2021-2024 | Verquvo |
| Cvrx, INC. | $128.68 | 2022-2024 | Barostim Neo System |
| Steris Corporation | $125.00 | 2020 | |
| Cardiovascular Systems INC. | $124.93 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $119.23 | 2024-2025 | Lifevest |
| Amgen INC. | $110.68 | 2019-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $102.82 | 2019-2023 | Jardiance |
| Novo Nordisk INC | $93.20 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Esperion Therapeutics, INC. | $83.79 | 2023-2024 | Nexletol |
| Acist Medical Systems, INC. | $81.09 | 2019 | |
| Stryker Corporation | $79.19 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $76.44 | 2022-2025 | |
| Recor Medical INC | $58.17 | 2025 | Paradise Ultrasound Renal Denervation System |
| Angiodynamics, INC. | $45.30 | 2024 | Alphavac |
| Atricure, INC. | $42.50 | 2024 | |
| Gilead Sciences, INC. | $32.60 | 2019 | |
| Terumo Medical Corporation | $23.69 | 2022 | |
| Amarin Pharma, INC. | $20.18 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $18.72 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $18.44 | 2023 | Brilinta |
| Ethicon US, LLC | $16.52 | 2020 | |
| Cordis US Corp. | $16.24 | 2024 | Mynx Control |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,575.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Reitman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.